These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4907560)

  • 1. L-Dopa and Parkinsonism.
    Calne DB; Sandler M
    Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract]   [Full Text] [Related]  

  • 2. L-Dopa in the treatment of parkinsonism.
    Calne DB
    Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of parkinsonism (a review).
    Klawans HL
    Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical implications of the use of L-dopa in parkinsonism. A review.
    Klawans H; Ilahi MM; Shenker D
    Acta Neurol Scand; 1970; 46(4):409-41. PubMed ID: 4323341
    [No Abstract]   [Full Text] [Related]  

  • 6. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
    Gattringer B; Steinhäusl H
    Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transmethylating activity in vitro in patients with parkinsonism before and after treatment with L-dopa].
    Carella A; Valenti P; Buscaino GA
    Acta Neurol (Napoli); 1971; 26(1):41-5. PubMed ID: 5553940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the treatment of parkinsonism].
    Dowzenko A
    Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308
    [No Abstract]   [Full Text] [Related]  

  • 10. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
    Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
    J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
    Hornykiewicz O
    Br Med Bull; 1973 May; 29(2):172-8. PubMed ID: 4356552
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals.
    Black IB; Hendry I; Iversen LL
    Nat New Biol; 1971 May; 231(18):27-9. PubMed ID: 5282850
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain.
    Uretsky NJ; Iversen LL
    J Neurochem; 1970 Feb; 17(2):269-78. PubMed ID: 5494056
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of noradrenaline biosynthesis in nerve tissue.
    Stjärne L
    Acta Physiol Scand; 1966; 67(3):441-54. PubMed ID: 5967606
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
    Lhermitte F; Rosa A; Comoy E; Bohuon C
    Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.
    Bak IJ; Hassler R; Kim JS; Kataoka K
    J Neural Transm; 1972; 33(1):45-61. PubMed ID: 4674484
    [No Abstract]   [Full Text] [Related]  

  • 20. Biosynthesis and metabolism of the catecholamines.
    Sandler M
    Schweiz Med Wochenschr; 1970 Mar; 100(12):526-31. PubMed ID: 4906882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.